Literature DB >> 29927768

An Update on the Basic and Clinical Science of Ketamine Analgesia.

Lisa V Doan1, Jing Wang1,2.   

Abstract

OBJECTIVE: In the context of the current opioid epidemic, there has been a renewed interest in the use of ketamine as an analgesic agent.
METHODS: We reviewed ketamine analgesia.
RESULTS: Ketamine is well-known as an antagonist for N-methyl-D-aspartate receptors. In addition, it can regulate the function of opioid receptors and sodium channels. Ketamine also increases signaling through α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. These myriad of molecular and cellular mechanisms are responsible for a number of pharmacological functions including pain relief and mood regulation. Clinically, a number of studies have investigated the role of ketamine in the setting of acute and chronic pain, and there is evidence that ketamine can provide analgesia in a variety of pain syndromes. DISCUSSION: In this review, we examined basic mechanisms of ketamine and its current clinical use and potential novel use in pain management.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29927768     DOI: 10.1097/AJP.0000000000000635

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  4 in total

Review 1.  Suicide Has Many Faces, So Does Ketamine: a Narrative Review on Ketamine's Antisuicidal Actions.

Authors:  Aiste Lengvenyte; Emilie Olié; Philippe Courtet
Journal:  Curr Psychiatry Rep       Date:  2019-12-03       Impact factor: 5.285

2.  Perioperative Use of Gabapentinoids: Comment.

Authors:  Po-Yi Paul Su; Zhonghui Guan
Journal:  Anesthesiology       Date:  2021-04-01       Impact factor: 7.892

3.  The effect of ketamine on preventing postpartum depression.

Authors:  Mina Alipoor; Marzeyeh Loripoor; Majid Kazemi; Farshid Farahbakhsh; Ali Sarkoohi
Journal:  J Med Life       Date:  2021 Jan-Mar

4.  Disrupted population coding in the prefrontal cortex underlies pain aversion.

Authors:  Anna Li; Yaling Liu; Qiaosheng Zhang; Isabel Friesner; Hyun Jung Jee; Zhe Sage Chen; Jing Wang
Journal:  Cell Rep       Date:  2021-11-09       Impact factor: 9.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.